# Deflazacort

NDC: 0054-0826
Generic name: Deflazacort
Labeler / Manufacturer: Hikma Pharmaceuticals USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20261007

FDA application: ANDA220524

## Active ingredients

- DEFLAZACORT: 30 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0054-0826"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0054-0826